Program Pricing
$99/for the first month
$199/per month thereafter
A Non-Injectable Option for Weight Management
A Non-Injectable Option for Weight Management
Weight loss is often way more difficult than it looks. It might even become discouraging when efforts do not match the results. Many adults stick to the weight loss plan, but they end up struggling with constant cravings and the body’s resistance to change. Medical weight loss is designed to address this.
Wegovy® pill is the first FDA-approved oral GLP-1 option for eligible patients who prefer a non-injectable approach. At Seattle Plastic Surgery, Wegovy® prescriptions are provided only after a careful medical assessment to ensure suitability.
The Wegovy® pill is a prescription medication designed to support medical weight management in eligible adults. Unlike many GLP-1 medications that require injections, Wegovy® tablets are taken once daily orally. The medication contains semaglutide, an FDA-approved ingredient that helps control appetite by making you feel full sooner and reducing hunger between meals.
Wegovy® pills are not a quick fix or a diet substitute. They are intended to be used alongside healthy eating habits, regular physical activity, and ongoing medical guidance.
Many people struggle with weight because of constant hunger cravings, even when they are eating well. Wegovy® is designed to work with the body’s natural systems that control appetite. After meals, the body releases a hormone called GLP-1 that signals fullness and helps regulate how much you eat.
As a result, Wegovy® may help patients:
When combined with a healthy diet and regular exercise, Wegovy® pills can support sustainable weight loss.
Adults who may qualify for Wegovy® tablets in Seattle include:
At Seattle Plastic Surgery, we offer a comprehensive consultation to determine eligibility. During your evaluation, we review:
To ensure Wegovy® is absorbed properly and works as intended, it should be taken exactly as prescribed. FDA guidelines include the following instructions:
If you miss a dose, skip it and take the next dose at your usual time the following day.
Wegovy® pills are started at a low dose and slowly increased over time. This gradual approach may help reduce stomach side effects and give the body time to adjust. Some patients may move through doses faster or slower depending on how they feel. Common dosing schedules for adults include:
Only one tablet should be taken per day. If side effects occur, we may suggest staying at a lower dose longer before advancing.
In clinical research, adults who took Wegovy® tablets daily and followed the plan lost an average of about 16–17% of their body weight. Results may vary based on the following:
GLP-1 medications, including Wegovy®, can affect the digestive system, especially when starting or increasing doses. Some patients may experience:
These effects often wear off as the body adjusts. To help reduce discomfort, patients may be advised to:
We can adjust dosing and suggest strategies to support tolerance.
Wegovy® is a prescription medication and should be used only under medical supervision. Before prescribing, we review your complete health profile to ensure it is a safe and appropriate option. Here are some important considerations:
We will walk you through these considerations and provide ongoing support.
A Wegovy® pill prescription starts with a thorough consultation to assess eligibility, review medical history, and answer questions about the treatment process. At Seattle Plastic Surgery, we offer:
Call us at 206-324-1120 to schedule a consultation and discuss your options.
Yes. Wegovy® tablets are FDA-approved for chronic weight management in eligible adults.
Both contain semaglutide, but one is oral and the other is injectable. We will help determine which option, if any, is appropriate.
Wegovy® tablets should be taken once daily on an empty stomach with water only. Wait for 30 minutes before food or other medications.
If you miss a dose, skip it and take the next scheduled dose the following day. Do not double up.
Common side effects may include nausea, diarrhea, vomiting, constipation, stomach discomfort, headache, and fatigue.
Wegovy® is not recommended for patients with a history of medullary thyroid carcinoma or MEN 2.
Costs vary based on insurance coverage, pharmacy pricing, and savings programs, and are best discussed during consultation.